Myriad Genetics
MYGN
MYGN
190 hedge funds and large institutions have $1.06B invested in Myriad Genetics in 2020 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 70 increasing their positions, 60 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
53% less call options, than puts
Call options by funds: $2.69M | Put options by funds: $5.68M
64% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 50
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
190
Holding in Top 10
–
Calls
$2.69M
Puts
$5.68M
Top Buyers
| 1 | +$19.3M | |
| 2 | +$17.3M | |
| 3 | +$11.1M | |
| 4 |
EARNEST Partners
Atlanta,
Georgia
|
+$8.04M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$5.23M |
Top Sellers
| 1 | -$34.8M | |
| 2 | -$27.3M | |
| 3 | -$24.2M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$16.7M |
| 5 |
GACM
Global Alpha Capital Management
Montreal,
Quebec, Canada
|
-$13.2M |